Insider Stock Trading History of Foote Susan Bartlett


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Foote Susan Bartlett since year 2005. The trader's CIK number is 1244063. At the time of this reporting, Foote Susan Bartlett is the Director of Haemonetics Corp . (stock ticker symbol HAE). See this page for all insider trading activities at Haemonetics Corp .


Stock purchases, sales, and option exercises reported by insider Foote Susan Bartlett since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-10 HAE Haemonetics Corp Option Ex 16,926 40.48 685,096
2017-11-10 HAE Haemonetics Corp Sale 16,926 54.22 917,727
2017-05-11 HAE Haemonetics Corp Sale 15,314 41.78 639,818
2017-05-11 HAE Haemonetics Corp Option Ex 15,314 35.39 541,931
2016-08-05 HAE Haemonetics Corp Option Ex 8,580 27.24 233,719
2016-08-05 HAE Haemonetics Corp Sale 14,685 35.34 518,997
2015-03-10 HAE Haemonetics Corp Option Ex 11,328 29.23 331,117
2015-03-10 HAE Haemonetics Corp Sale 11,328 43.84 496,642
2014-05-12 HAE Haemonetics Corp Option Ex 9,184 24.96 229,232
2014-05-12 HAE Haemonetics Corp Sale 9,184 33.16 304,550
2013-11-12 HAE Haemonetics Corp Sale 2,062 39.82 82,108
2012-09-07 HAE Haemonetics Corp Sale 6,000 75.90 455,406
2012-09-07 HAE Haemonetics Corp Option Ex 6,000 52.76 316,560
2011-05-05 HAE Haemonetics Corp Sale 6,000 67.67 405,990
2011-05-05 HAE Haemonetics Corp Option Ex 6,000 44.74 268,440
2008-12-08 HAE Haemonetics Corp Sale 20,000 58.00 1,160,000
2008-12-08 HAE Haemonetics Corp Option Ex 20,000 29.89 597,900
2005-11-22 HAE Haemonetics Corp Buy 1,000 49.25 49,246
2005-11-22 HAE Haemonetics Corp Buy 1,000 49.25 49,246

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Foote Susan Bartlett (Director of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.